Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 161

1.

Utility of the Parkinson's disease-Cognitive Rating Scale for the screening of global cognitive status in Huntington's disease.

Martinez-Horta S, Horta-Barba A, Perez-Perez J, Sampedro F, de Lucia N, De Michele G, Kehrer S, Priller J, Migliore S, Squitieri F, Castaldo A, Mariotti C, Mañanes V, Lopez-Sendon JL, Rodriguez N, Martinez-Descals A, Garcia-Ruiz P, Júlio F, Januário C, Delussi M, de Tommaso M, Noguera S, Ruiz-Idiago J, Sitek EJ, Nuzzi A, Pagonabarraga J, Kulisevsky J; Cognitive Phenotype Working Group of the European Huntington’s Disease Network.

J Neurol. 2020 Feb 7. doi: 10.1007/s00415-020-09730-6. [Epub ahead of print]

PMID:
32030521
2.

Frontal defect contribution to decreasing of body mass index in Parkinson's disease patients.

De Lucia N, Peluso S, Esposito M, Masi A, Saccà F, Bruzzese D, De Michele G, De Rosa A.

J Clin Neurosci. 2020 Feb;72:229-232. doi: 10.1016/j.jocn.2019.11.034. Epub 2019 Dec 12.

PMID:
31839381
3.

Perseverative Behavior on Verbal Fluency Task in Patients with Huntington's Disease: a Retrospective Study on a Large Patient Sample.

De Lucia N, Peluso S, Roca A, De Michele G, Trojano L, Salvatore E.

Arch Clin Neuropsychol. 2019 Dec 8. pii: acz052. doi: 10.1093/arclin/acz052. [Epub ahead of print]

PMID:
31813981
4.

Overt Hypogonadism May Not Be a Sentinel Sign of RING Finger Protein 216: Two Novel Mutations Associated with Ataxia, Chorea, and Fertility.

Lieto M, Galatolo D, Roca A, Cocozza S, Pontillo G, Fico T, Pane C, Saccà F, De Michele G, Santorelli FM, Filla A.

Mov Disord Clin Pract. 2019 Oct 23;6(8):724-726. doi: 10.1002/mdc3.12839. eCollection 2019 Nov. No abstract available.

PMID:
31745488
5.

International Guidelines for the Treatment of Huntington's Disease.

Bachoud-Lévi AC, Ferreira J, Massart R, Youssov K, Rosser A, Busse M, Craufurd D, Reilmann R, De Michele G, Rae D, Squitieri F, Seppi K, Perrine C, Scherer-Gagou C, Audrey O, Verny C, Burgunder JM.

Front Neurol. 2019 Jul 3;10:710. doi: 10.3389/fneur.2019.00710. eCollection 2019.

6.

PERK-Mediated Unfolded Protein Response Activation and Oxidative Stress in PARK20 Fibroblasts.

Amodio G, Moltedo O, Fasano D, Zerillo L, Oliveti M, Di Pietro P, Faraonio R, Barone P, Pellecchia MT, De Rosa A, De Michele G, Polishchuk E, Polishchuk R, Bonifati V, Nitsch L, Pierantoni GM, Renna M, Criscuolo C, Paladino S, Remondelli P.

Front Neurosci. 2019 Jun 27;13:673. doi: 10.3389/fnins.2019.00673. eCollection 2019.

7.

Searching for Potential Lipid Biomarkers of Parkinson's Disease in Parkin-Mutant Human Skin Fibroblasts by HILIC-ESI-MS/MS: Preliminary Findings.

Calvano CD, Ventura G, Sardanelli AMM, Savino L, Losito I, Michele G, Palmisano F, Cataldi TRI.

Int J Mol Sci. 2019 Jul 7;20(13). pii: E3341. doi: 10.3390/ijms20133341.

8.

Screening for Niemann-Pick type C disease in neurodegenerative diseases.

Boenzi S, Dardis A, Russo P, Bellofatto M, Imbriglio T, Fico T, De Michele G, De Rosa A.

J Clin Neurosci. 2019 Oct;68:266-267. doi: 10.1016/j.jocn.2019.06.025. Epub 2019 Jun 17.

PMID:
31221578
9.

Using global team science to identify genetic parkinson's disease worldwide.

Vollstedt EJ, Kasten M, Klein C; MJFF Global Genetic Parkinson's Disease Study Group.

Ann Neurol. 2019 Aug;86(2):153-157. doi: 10.1002/ana.25514. Epub 2019 Jun 26. No abstract available.

PMID:
31155756
10.

Longitudinal study of a cohort of MSA-C patients in South Italy: survival and clinical features.

Lieto M, Roca A, Bruzzese D, Antenora A, Alfieri G, Saccà F, Bellofatto M, Bilo L, Barbato S, De Michele G, Filla A.

Neurol Sci. 2019 Oct;40(10):2105-2109. doi: 10.1007/s10072-019-03948-7. Epub 2019 May 31.

PMID:
31152261
11.

LRP10 variants in Parkinson's disease and dementia with Lewy bodies in the South-West of the Netherlands.

Vergouw LJM, Ruitenberg A, Wong TH, Melhem S, Breedveld GJ, Criscuolo C, De Michele G, de Jong FJ, Bonifati V, van Swieten JC, Quadri M.

Parkinsonism Relat Disord. 2019 Aug;65:243-247. doi: 10.1016/j.parkreldis.2019.05.037. Epub 2019 May 25.

PMID:
31147221
12.

Spinocerebellar ataxia 48 presenting with ataxia associated with cognitive, psychiatric, and extrapyramidal features: A report of two Italian families.

De Michele G, Lieto M, Galatolo D, Salvatore E, Cocozza S, Barghigiani M, Tessa A, Baldacci J, Pappatà S, Filla A, De Michele G, Santorelli FM.

Parkinsonism Relat Disord. 2019 Aug;65:91-96. doi: 10.1016/j.parkreldis.2019.05.001. Epub 2019 May 14.

PMID:
31126790
13.

Degenerative and acquired sporadic adult onset ataxia.

Lieto M, Roca A, Santorelli FM, Fico T, De Michele G, Bellofatto M, Saccà F, De Michele G, Filla A.

Neurol Sci. 2019 Jul;40(7):1335-1342. doi: 10.1007/s10072-019-03856-w. Epub 2019 Mar 29. Review.

PMID:
30927137
14.

The flavor test is a sensitive tool in identifying the flavor sensorineural dysfunction in Parkinson's disease.

De Rosa A, Nettore IC, Cantone E, Maione L, Desiderio S, Peluso S, Saccà F, Manganelli F, Bruzzese D, Colao A, De Michele G, Macchia PE.

Neurol Sci. 2019 Jul;40(7):1351-1356. doi: 10.1007/s10072-019-03842-2. Epub 2019 Mar 20.

PMID:
30895397
15.

Primary familial brain calcification caused by a novel homozygous MYORG mutation in a consanguineous Italian family.

Ramos EM, Roca A, Chumchim N, Dokuru DR, Van Berlo V, De Michele G, Lieto M, Tedeschi E, De Michele G, Coppola G.

Neurogenetics. 2019 May;20(2):99-102. doi: 10.1007/s10048-019-00571-8. Epub 2019 Mar 21.

PMID:
30895394
16.

Mutations in the SPAST gene causing hereditary spastic paraplegia are related to global topological alterations in brain functional networks.

Rucco R, Liparoti M, Jacini F, Baselice F, Antenora A, De Michele G, Criscuolo C, Vettoliere A, Mandolesi L, Sorrentino G, Sorrentino P.

Neurol Sci. 2019 May;40(5):979-984. doi: 10.1007/s10072-019-3725-y. Epub 2019 Feb 8.

17.

Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study.

Reilmann R, McGarry A, Grachev ID, Savola JM, Borowsky B, Eyal E, Gross N, Langbehn D, Schubert R, Wickenberg AT, Papapetropoulos S, Hayden M, Squitieri F, Kieburtz K, Landwehrmeyer GB; European Huntington's Disease Network; Huntington Study Group investigators.

Lancet Neurol. 2019 Feb;18(2):165-176. doi: 10.1016/S1474-4422(18)30391-0. Epub 2018 Dec 15.

PMID:
30563778
18.

DNA damage signatures in peripheral blood cells as biomarkers in prodromal huntington disease.

Castaldo I, De Rosa M, Romano A, Zuchegna C, Squitieri F, Mechelli R, Peluso S, Borrelli C, Del Mondo A, Salvatore E, Vescovi LA, Migliore S, De Michele G, Ristori G, Romano S, Avvedimento EV, Porcellini A.

Ann Neurol. 2019 Feb;85(2):296-301. doi: 10.1002/ana.25393. Epub 2019 Jan 13.

PMID:
30549309
19.

Reversible Valproate-Induced Subacute Encephalopathy Associated With a MT-ATP8 Variant in the Mitochondrial Genome.

De Michele G, Sorrentino P, Nesti C, Rubegni A, Ruggiero L, Peluso S, Antenora A, Quarantelli M, Filla A, De Michele G, Santorelli FM.

Front Neurol. 2018 Aug 30;9:728. doi: 10.3389/fneur.2018.00728. eCollection 2018.

20.

Reduced Cancer Incidence in Huntington's Disease: Analysis in the Registry Study.

McNulty P, Pilcher R, Ramesh R, Necuiniate R, Hughes A, Farewell D, Holmans P, Jones L; REGISTRY Investigators of the European Huntington's Disease Network.

J Huntingtons Dis. 2018;7(3):209-222. doi: 10.3233/JHD-170263.

PMID:
30103338

Supplemental Content

Loading ...
Support Center